These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3044367)

  • 1. Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.
    Ballin M; Gomez DE; Sinha CC; Thorgeirsson UP
    Biochem Biophys Res Commun; 1988 Aug; 154(3):832-8. PubMed ID: 3044367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.
    Garbisa S; Pozzatti R; Muschel RJ; Saffiotti U; Ballin M; Goldfarb RH; Khoury G; Liotta LA
    Cancer Res; 1987 Mar; 47(6):1523-8. PubMed ID: 3028610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of endothelial cell matrix collagen is correlated with induction of stromelysin by an activated ras oncogene.
    LoSardo JE; Goggin BS; Bohoslawec O; Neri A
    Clin Exp Metastasis; 1995 Jul; 13(4):236-48. PubMed ID: 7606886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues.
    Ballin M; Mackay AR; Hartzler JL; Nason A; Pelina MD; Thorgeirsson UP
    Clin Exp Metastasis; 1991; 9(2):179-89. PubMed ID: 2032422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of a gelatin-degrading type IV collagenase secreted by ras oncogene-transformed fibroblasts.
    Spinucci C; Zucker S; Wieman JM; Lysik RM; Imhof B; Ramamurthy N; Liotta LA; Nagase H
    J Natl Cancer Inst; 1988 Nov; 80(17):1416-20. PubMed ID: 2845110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
    Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
    Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.
    Rimoldi D; Srikantan V; Wilson VL; Bassin RH; Samid D
    Cancer Res; 1991 Jan; 51(1):324-30. PubMed ID: 1703037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic NIH 3T3 x LTA cell hybrids express 72 kDa type IV collagenase.
    Xuan JW; Wilson SM; Chin JL; Chambers AF
    Anticancer Res; 1995; 15(4):1227-33. PubMed ID: 7654002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
    Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of a connective-tissue-degrading metalloproteinase from the cytosol of metastatic melanoma cells.
    Zucker S; Turpeenniemi-Hujanen T; Ramamurthy N; Wieman J; Lysik R; Gorevic P; Liotta LA; Simon SR; Golub LM
    Biochem J; 1987 Jul; 245(2):429-37. PubMed ID: 3663169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type IV collagenolytic activity linkage with the metastatic phenotype induced by ras transfection.
    Garbisa S; Negro A; Kalebic T; Pozzatti R; Muschel R; Saffiotti U; Liotta LA
    Adv Exp Med Biol; 1988; 233():179-86. PubMed ID: 2851926
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
    Azzam HS; Arand G; Lippman ME; Thompson EW
    J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review).
    Boylan JF; Jackson J; Steiner MR; Shih TY; Duigou GJ; Roszman T; Fisher PB; Zimmer SG
    Anticancer Res; 1990; 10(3):717-24. PubMed ID: 2195986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
    Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
    Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated production of metalloproteinases in Ki-ras-transformed human osteosarcoma cells.
    Chan JC; Song WT
    Leukemia; 1994 Apr; 8 Suppl 1():S30-5. PubMed ID: 8152301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen.
    Murphy G; McAlpine CG; Poll CT; Reynolds JJ
    Biochim Biophys Acta; 1985 Sep; 831(1):49-58. PubMed ID: 2994741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
    Xia T; Akers K; Eisen AZ; Seltzer JL
    Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells.
    Wilhelm SM; Collier IE; Kronberger A; Eisen AZ; Marmer BL; Grant GA; Bauer EA; Goldberg GI
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6725-9. PubMed ID: 3477804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.